Recall: Defective Droppers Packaged with Anti-Anxiety Drug

By August 15, 2017

The dosing droppers, supplied by a third party, were misprinted with the dose markings in reverse number, shifted dose markings or no dose markings.

Cannabis Efficacy Examined in Patients with Chronic Pain, PTSD

August 15, 2017

The researchers found low-strength evidence that cannabis alleviates neuropathic pain based on 27 chronic pain trials; insufficient evidence was found in other pain populations.

PANS/PANDAS Treatment Guidelines Released

By July 20, 2017

"Immunomodulatory therapy should be considered early, because NSAIDs or a short course of oral corticosteroids may be sufficient for symptom remission in recent-onset cases, whereas those with long-standing symptoms often require more intensive and prolonged immunotherapeutic interventions," the authors write.

Do Benzodiazepines Increase the Risk of All Cause Mortality?

By July 19, 2017

A total of 5,061 and 4,691 deaths occurred in the high dimensional propensity score matched benzodiazepine initiators compared to non-initiators, which equated to 9.3 vs. 9.4 events per 1,000 person years, respectively (HR 1.00, 95% CI, 0.96-1.04).

From Treatment to Training: 5 Uses of Virtual Reality in Healthcare

June 27, 2017

Virtual reality is much more than just a new form of entertainment, it is increasingly being used in a wide range of medical applications.

C.O. Truxton Expands Recall of Drugs with Possible Label Mix-Ups

By May 09, 2017

The C.O. Truxton product is packaged in 100- or 1000-count bottles in the following strengths: 15mg, 30mg, 60mg, and 100mg.

Review: Evaluating Patients for Primary Exercise Addiction

April 27, 2017

Practitioners can evaluate a patient for exercise addiction by exploring a patient's motivation for exercise, determining whether they cut back when injured, exploring the patient's emotional connection to exercise, and assessing whether exercise interferes with other aspects of life.

Intranasal Drug Delivery Increasingly Popular in the ER

April 24, 2017

Many benefits to nasal administration, including reduction in spread of infection

Mislabeled Phenobarbital Bottles Prompt Recall

By April 21, 2017

The mislabeled drug could lead to a potential overdose for patients or their pet(s), resulting in severe intoxication, cardiogenic shock, renal failure, coma or death.

Can Hypnosis Improve Post-Op Anxiety, Pain in Children?

April 19, 2017

Findings among pediatric patients undergoing major orthopedic surgery

Benzodiazepine Use Among Alzheimer's Patients May Up Pneumonia Risk

By April 10, 2017

Analysis found that the use of benzodiazepines was significantly associated with an increased risk of pneumonia (aHR 1.28, 95% CI: 1.07-1.54) but not for the similarly acting non-benzodiazepines (aHR 1.10, 95% CI: 0.84-1.44).

Upsher-Smith Launches Generic Anafranil

By March 27, 2017

Clomipramine HCl carries a boxed warning regarding the increased risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders.

How Likely Are Teens to Seek Treatment for Eating Disorders?

March 27, 2017

Adolescents who met criteria for anorexia nervosa or bulimia nervosa were 2.4 and 1.9 times, respectively, more likely to seek treatment than adolescents who met criteria for binge-eating disorder.

Treatment Strategies for Benzodiazepine Dependence

March 23, 2017

Good evidence for cognitive behavioral therapy and motivational approaches to dependence

Mental Health Tx Rejection Greater When Only Meds Used

March 07, 2017

A total of 186 studies of patients who sought help for mental health conditions were analyzed, overall, the average treatment refusal rate was 8.2%.

Prescriptions for Risky Drug Combinations on the Rise Among Seniors

February 14, 2017

Between 2004 and 2013 the number of polypharmacy outpatients visits by adults over 65 years almost doubled.

Links Examined Between Mental Health and Site Specific Cancers

January 27, 2017

Anxiety and depression may increase the risk of death from certain cancers, according to research published online January 25 in The BMJ.

MAPS Looks to Make MDMA into an FDA-Approved Psychotropic Agent

By January 26, 2017

Based on Phase 2 studies, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy could be a potential treatment option for several psychiatric conditions, however turning this controlled substance into a therapeutic agent is contingent upon successful Phase 3 trials and regulatory approval.

Greater Support Needed for Partners of Cancer Patients

January 25, 2017

Breast cancer can take a heavy toll on the partners of patients, too, according to a study presented at the American Society of Clinical Oncology's Cancer Survivorship Symposium, held from in San Diego

Tablet Splitting and Liquid Dosing: Factors that Influence Accuracy

By January 24, 2017

Researchers sought to determine factors that influence accurate tablet splitting and liquid dosing by patients as compared to healthcare professionals.

Comorbid Panic Disorder May Up Risk of Antidepressant Side Effects

By January 04, 2017

An analysis published in the Journal of Clinical Psychiatry reports that chronically depressed patients with panic disorder may be at greater risk for experiencing antidepressant side effects than patients without panic disorder.

Do Pre-Existing Psychiatric Conditions Impact Opioid Use?

By December 29, 2016

Study authors reported evidence of greater opioid receipt among commercially insured patients with a wide range of psychiatric conditions.

Drug vs. Cognitive Therapy Compared in Social Anxiety Disorder

December 27, 2016

Finding in small, randomized trial evaluating paroxetine alone or in combo with therapy

Study: The 10 Most Frequently Used Psychiatric Drugs in the U.S.

December 13, 2016

One in six U.S. adults take a psychiatric medication to treat conditions such as depression, anxiety, and insomnia, according to a study published online in JAMA Internal Medicine.

Anxiety, Depression Significantly Higher in Those With Hyperhidrosis

November 21, 2016

Hyperhidrosis (HH) is associated with increased prevalence of anxiety and depression, in a HH severity-dependent manner, according to a study published in the Journal of the American Academy of Dermatology.

Early Improvement With Vilazodone Might Predict Response, Remission in GAD

By October 23, 2016

Sufficient dosing and treatment duration might be needed to assess vilazodone's effectivness for management of symptoms among patients with GAD, concluded authors of a pooled analysis of data from three phase 3 clinical trials.

Long-Term Efficacy Data Added to Binge Eating Disorder Drug Labeling

By October 17, 2016

Shire announced that the labeling for Vyvanse (lisdexamfetamine dimesylate) has been updated to include data regarding the approval of a supplemental New Drug Application (sNDA).

United Stress of America: Election Causing Stress for Many Americans

October 14, 2016

The U.S. presidential election has caused stress for more than half of American adults, regardless of party affiliation, according to a survey conducted by the American Psychological Association.

Time of Day of Cortisol Admin Effects Outcomes in Psychotherapy

October 12, 2016

For patients with panic disorder with agoraphobia, cortisol mediates the effect of the time of day on subsequent outcome, with greater clinical improvement seen for earlier exposure sessions, according to a study published in the Psychoneuroendocrinology.

Certain Perinatal Factors May Up a Child's Risk for OCD

October 07, 2016

Smoking, method of delivery, birth weight, low Apgar -- all appear to contibute to greater risk